# Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL)

> **NCT01875952** · PHASE4 · UNKNOWN · sponsor: **Instituto Nacional de Salud Publica, Mexico** · enrollment: 100 (estimated)

## Conditions studied

- Human Immunodeficiency Virus (HIV)
- Tuberculosis (TB)
- Latent Tuberculosis Infection (LTI)

## Interventions

- **DRUG:** Isoniazid

## Key facts

- **NCT ID:** NCT01875952
- **Lead sponsor:** Instituto Nacional de Salud Publica, Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-05
- **Primary completion:** 2012-06
- **Final completion:** 2013-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2013-06-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01875952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01875952, "Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01875952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*